Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling

In-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is 5–6%. Consequently, it is necessary to develop fundamentally novel drugs capable of reducing mortality in patients with acute myocardial infarction. Apelins could be the prototype for such drugs. Chronic adm...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sergey V. Popov, Leonid N. Maslov, Alexandr V. Mukhomedzyanov, Boris K. Kurbatov, Alexandr S. Gorbunov, Michail Kilin, Viacheslav N. Azev, Maria S. Khlestkina, Galina Z. Sufianova
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2023-03-01
Serie:	Pharmaceutics
Soggetti:	heart ischemia/reperfusion apelin adverse remodeling
Accesso online:	https://www.mdpi.com/1999-4923/15/3/1029
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!